A child with severe juvenile dermatomyositis treated with ruxolitinib | Zendy

Florence A. Aeschlimann | Zendy; MarieLouise Frémond | Zendy; Darragh Duffy | Zendy; Gillian Rice | Zendy; JeanLuc Charuel | Zendy; Vincent Bondet | Zendy; Elsa Saire | Zendy; Bénédicte Neven | Zendy; Christine Bodemer | Zendy; Laurent Balu | Zendy; Cyril Gitiaux | Zendy; Yanick J. Crow | Zendy; Brigitte BaderMeunier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A child with severe juvenile dermatomyositis treated with ruxolitinib

Author(s) -

Florence A. Aeschlimann,

MarieLouise Frémond,

Darragh Duffy,

Gillian Rice,

JeanLuc Charuel,

Vincent Bondet,

Elsa Saire,

Bénédicte Neven,

Christine Bodemer,

Laurent Balu,

Cyril Gitiaux,

Yanick J. Crow,

Brigitte BaderMeunier

Publication year - 2018

Publication title -

brain

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.142

H-Index - 336

eISSN - 1460-2156

pISSN - 0006-8950

DOI - 10.1093/brain/awy255

Subject(s) - ruxolitinib , janus kinase , juvenile dermatomyositis , medicine , tyrosine kinase 2 , janus kinase 1 , stat2 , dermatomyositis , stat protein , stat1 , kinase , tyrosine kinase , oncology , immunology , signal transduction , stat3 , receptor , myelofibrosis , biology , bone marrow , biochemistry , platelet derived growth factor receptor , growth factor , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research